Rispondi Cancella risposta
Questo sito utilizza Akismet per ridurre lo spam. Scopri come vengono elaborati i dati derivati dai commenti.
Follow MEDEST on Twitter
- The MEDEST118 Daily is out! paper.li/MEDEST118/1407… Stories via @ClinMedJournals @peds211908 @crit_cloud #foamed #sjtrem 1 hour ago
- The MEDEST118 Daily is out! paper.li/MEDEST118/1407… Stories via @srrezaie #foamed #radiology 1 day ago
- RT @ketaminh: @MEDEST118 @fabiodeiaco @MarioGuarino4 Grazie mille! https://t.co/cMhTynqbVO 1 day ago
- RT @ketaminh: All about ketamine with MEDEST118 prehospitalmed.com/2021/01/22/all… 1 day ago
- All about Ketamine. With @ketaminh @fabiodeiaco @MarioGuarino4 . Watching the live recording fb.watch/39AuRx_VVx/ 1 day ago
Articoli recenti
- La “constatazione” di decesso. Storia presunta e non-fondamento legislativo di una leggenda metropolitana. 27 agosto 2020
- Open Chest Wounds. The Prehospital Management 3 agosto 2020
- E’ andato tutto bene? 19 maggio 2020
- Beyond Advanced Cardiac Life Support. Do we have to change our practice in COVID Era? 3 maggio 2020
- Airway management in COVID-19 era 9 aprile 2020
- Supporto respiratorio non invasivo e gestione delle vie aeree in epoca COVID 2 aprile 2020
- Respiratory support in suspected COVID-19 patients. When conventional O2 therapy is not enough! 20 marzo 2020
The MEDEST on line News
Paperli.PaperWidget.Show({pid: '71aba46f-dee1-4148-93c6-c1537be7ba8a', width: 200, background: '#FB0000'})
Archivi
MyTweet
- The MEDEST118 Daily is out! paper.li/MEDEST118/1407… Stories via @ClinMedJournals @peds211908 @crit_cloud #foamed #sjtrem 1 hour ago
- The MEDEST118 Daily is out! paper.li/MEDEST118/1407… Stories via @srrezaie #foamed #radiology 1 day ago
- RT @ketaminh: @MEDEST118 @fabiodeiaco @MarioGuarino4 Grazie mille! https://t.co/cMhTynqbVO 1 day ago
- RT @ketaminh: All about ketamine with MEDEST118 prehospitalmed.com/2021/01/22/all… 1 day ago
- All about Ketamine. With @ketaminh @fabiodeiaco @MarioGuarino4 . Watching the live recording fb.watch/39AuRx_VVx/ 1 day ago
- @ketaminh @fabiodeiaco @MarioGuarino4 Guys that’s the best part of our job. Sharing clinical and life experiences w… twitter.com/i/web/status/1… 1 day ago
Favourites FOAMED Blogs
- Emergenza-Urgenza 2.0
- ALL Ohio EM
- Triggerlab
- thinking critical care
- urgentcareultrasound
- MariaLuisaRuberto.com
- Critical Care Northampton
- OHCA research
- SonoStuff
- phemcast
- First10EM
- Songs or Stories
- airwayNautics
- resusNautics
- Life in the Fast Lane • LITFL • Medical Blog
- emDOCs.net - Emergency Medicine Education
- The Collective
- Dave on Airways
- FOAMcast
- Broome Docs
- St.Emlyn's
- BoringEM
- "CardioOnline"Basic and Advanced Cardiovascular medicine" Cariology" concepts and Review -Dr.Nabil Paktin,MD.FACC.دکتـور نبــــیل "پاکطــــین
- DOWNSTAIRS CARE OUT THERE BLOG
- EmergencyPedia
- Little Medic
- Prehospital and Retrieval Medicine - THE PHARM dedicated to the memory of Dr John Hinds
- Prehospital Emergency Medicine Blog
- Italy Customized Tour Operator in Florence
- GoogleFOAM
- EM Lyceum
- Pediatric EM Morsels
- KidsCareEverywhere
- EM Pills
- AmboFOAM
- FOAM4GP
- Rural Doctors Net
- Auckland HEMS
- ECHOARTE
- MEDEST
- ruralflyingdoc
- EM Basic
- KI Doc
- Emergency Live
- AMP EM
- www.podcastingformedicalprofessionals.com
- Academic Life in Emergency Medicine
- Comments on: Homepage
- Greater Sydney Area HEMS
Scrivi a MEDEST
New AHA/ASA Guidelines on Stroke: no news and doubts….remains the same!
4 FebNothing new under the sun for Stroke treatment!
AHA/ASA Stroke Guidelnes 2013 show no changes respect 2007 AHA Stroke Guidelines and 2009 Science Advisory From the Expansion of the Time Window for Treatment of Acute Ischemic Stroke
Intravenous thrombolysis with r-tPA remains indicated for patients with additional exclusion criteria within 3 and 4,5 hours based on ECASS3 trial.
In this time frame the treatment with r-tPA is still considered “off-label” (Food and Drug Administration has declined to extend the label).
Still no clear indication for treatment with Intraarterial Thrombolysis. New trials are expected to be out in late spring 2013.
So still doubts and a question about IST 3 Study:”The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen”
His conclusions demonstrated adverse outcome on major endpoints for 3 to 4,5 hrs time window.
New guidelines make no mention about this big and so expected trial and his findings!
References:
AHA/ASA Stroke Guidelnes 2013
AHA/ASA Stroke Guidelines 2013 Executive Summary
thennt Thrombolytics for stroke
Condividi:
Mi piace:
Correlati
Tag:emergency medicine, Emergency Medicine guidelines, Guidelines, Linee guida, medicina d'urgenza, Stroke